These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 17964040)

  • 1. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.
    Lipinski MJ; Biondi-Zoccai GG; Abbate A; Khianey R; Sheiban I; Bartunek J; Vanderheyden M; Kim HS; Kang HJ; Strauer BE; Vetrovec GW
    J Am Coll Cardiol; 2007 Oct; 50(18):1761-7. PubMed ID: 17964040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
    Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
    Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Xu JY; Liu D; Zhong Y; Huang RC
    Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials.
    Kang S; Yang YJ; Li CJ; Gao RL
    Coron Artery Dis; 2008 Aug; 19(5):327-35. PubMed ID: 18607170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.
    Gyöngyösi M; Wojakowski W; Lemarchand P; Lunde K; Tendera M; Bartunek J; Marban E; Assmus B; Henry TD; Traverse JH; Moyé LA; Sürder D; Corti R; Huikuri H; Miettinen J; Wöhrle J; Obradovic S; Roncalli J; Malliaras K; Pokushalov E; Romanov A; Kastrup J; Bergmann MW; Atsma DE; Diederichsen A; Edes I; Benedek I; Benedek T; Pejkov H; Nyolczas N; Pavo N; Bergler-Klein J; Pavo IJ; Sylven C; Berti S; Navarese EP; Maurer G;
    Circ Res; 2015 Apr; 116(8):1346-60. PubMed ID: 25700037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials.
    Zhang S; Sun A; Xu D; Yao K; Huang Z; Jin H; Wang K; Zou Y; Ge J
    Clin Cardiol; 2009 Aug; 32(8):458-66. PubMed ID: 19685520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Liu B; Duan CY; Luo CF; Ou CW; Sun K; Wu ZY; Huang H; Cheng CF; Li YP; Chen MS
    Int J Cardiol; 2014 Dec; 177(3):764-70. PubMed ID: 25465825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling.
    Appleton DL; Abbate A; Biondi-Zoccai GG
    Catheter Cardiovasc Interv; 2008 May; 71(6):772-81. PubMed ID: 18415952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials.
    de Jong R; Houtgraaf JH; Samiei S; Boersma E; Duckers HJ
    Circ Cardiovasc Interv; 2014 Apr; 7(2):156-67. PubMed ID: 24668227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Wang Z; Wang L; Su X; Pu J; Jiang M; He B
    Stem Cell Res Ther; 2017 Jan; 8(1):21. PubMed ID: 28129790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.